Q1 2025 Shalby Ltd Earnings Call Transcript
Key Points
- Shalby Ltd (BOM:540797) reported a 20% YoY increase in consolidated revenue, reaching INR 289 crores, the highest ever in the company's history.
- The company's implant business saw significant progress, generating revenues of INR 259 million, up by 58% YoY.
- EBITDA grew by 15% YoY to INR 55 crores, with a margin improvement from 19% to 20%.
- The company maintained a strong balance sheet with a low gearing ratio of 0.18x.
- Shalby Ltd (BOM:540797) successfully completed 29 transplants, including 9 kidneys, 15 livers, and 5 bone marrow transplants during the quarter.
- PAT decreased by 29% YoY to INR 15 crores, down from INR 21 crores in Q1 FY24.
- The implant business reported a minimal EBITDA loss of INR 66 lakhs due to marketing and sales promotion expenses.
- Sanar Hospital, recently acquired, reported an EBITDA loss of INR 35 lakhs for the quarter.
- The home care business saw a decline in the number of patients served, dropping from 7,695 in the previous quarter to 7,302.
- The company's overall occupancy rate remained low at 48%, with Sanar Hospital operating at just 25% occupancy.
Ladies and gentlemen, good day, and welcome to the Q1 FY25 Earnings Shalby Limited Conference Call hosted by Elara Securities Private Limited. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. Kashish Thakur from Elara Securities Private Limited. Thank you, and over to you, sir.
()-
Thank you, Saba. A very good evening to all of you on the call. On behalf of Elara Securities, I, Kashish Thakur, welcome you to the management call of Shalby Limited to discuss Q1 FY25 earnings and business outlook. We have the top management team of Shalby present in the call.
I now hand over the call to Mr. Jigar Todi from IR Team of Shalby for his opening remarks and taking it further. Over to you, Jigar.
Thanks, Kashish. Good afternoon, everyone. Our earnings presentation is uploaded on the stock
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
